Nonspecific urinary tract infection symptoms in infants <3 months are fever, feeding difficulties, vomiting, lethargy, irritability and failure to thrive.
Toddlers and preschoolers have unusual odor of urine, abdominal or flank pain, frequency, dysuria, and urgency.
School-age children have the classical symptoms of fever, frequency, urgency and dysuria.
Consider UTI in all seriously ill children even when there is evidence of infection outside the urinary tract.
Patients at risk of urinary tract infections (UTIs) are also highly likely to experience excessive weight gain, with risk factors including persistent reflux, younger age and Hispanic/Latino ethnicity, according to a secondary analysis of two prospective studies.
Treatment with antibiotic results in significant reduction in voiding cystourethrogram-associated urinary tract infection (UTI), especially in children with abnormal ultrasound scans, a study has found.
The presence of Escherichia coli and normal renal ultrasound findings may allow safe avoidance of voiding cystourethrography (VCUG), an invasive procedure associated with significant radiation exposure, in infants aged 0 to 3 months with a first febrile urinary tract infection (UTI), according to a recent study.
A diagnostic rule based on symptoms and signs performs better than clinical diagnosis in identifying young children who should undergo noninvasive urine testing for urinary tract infection (UTI) and guiding potential antibiotic treatment, as presented in the results of DUTY* Prospective Diagnostic Cohort Study.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS JPOG - Malaysia digital copy today!
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Long-term treatment with the interleukin-5
receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.